Innova Captab Limited
Canara Robeco Mutual Fund trimmed its stake in Innova Captab Limited from 3.61% to 3.47%, selling 80,665 shares.
An integrated pharmaceutical company operating across India's drug manufacturing and distribution value chain. Innova Captab develops, manufactures, and markets a diverse portfolio of pharmaceutical formulations for both domestic and international markets. The company maintains vertically integrated operations spanning multiple therapeutic areas, enabling control over production processes, quality management, and supply chain efficiency within the competitive Indian pharmaceutical sector.
Joint venture between Canara Bank and Robeco of Netherlands. Manages over Rs 1.5 lakh crore. Canara Robeco Equity Hybrid Fund and Canara Robeco Emerging Equities are among its best-regarded offerings with long consistent track records. Backed by the Canara Bank network for distribution across Tier 2 and Tier 3 India.